Ken Cheng

1.4k total citations
20 papers, 554 citations indexed

About

Ken Cheng is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ken Cheng has authored 20 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ken Cheng's work include PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers) and Malaria Research and Control (3 papers). Ken Cheng is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers) and Malaria Research and Control (3 papers). Ken Cheng collaborates with scholars based in United States, China and Japan. Ken Cheng's co-authors include James Inglese, Rajarshi Guha, Xin‐zhuan Su, Jing Yuan, Ronald L. Johnson, Sirisha Chakka, Fiona Newall, Vera Ignjatović, Anthony K.C. Chan and Anna Liu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ken Cheng

19 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Cheng United States 13 290 111 109 59 54 20 554
Anthony J. Chubb Ireland 15 280 1.0× 79 0.7× 43 0.4× 80 1.4× 198 3.7× 24 609
Caroline Aquino Moreira-Nunes Brazil 14 295 1.0× 116 1.0× 30 0.3× 72 1.2× 11 0.2× 68 541
Andrew K. Powell Australia 13 137 0.5× 71 0.6× 29 0.3× 19 0.3× 34 0.6× 23 423
Miki Kato Japan 14 172 0.6× 84 0.8× 49 0.4× 14 0.2× 25 0.5× 36 440
Marco Brughera Italy 12 113 0.4× 72 0.6× 125 1.1× 14 0.2× 31 0.6× 21 390
B.W. Noland United States 7 302 1.0× 75 0.7× 36 0.3× 62 1.1× 22 0.4× 9 702
Jason M. Gow United States 11 157 0.5× 266 2.4× 71 0.7× 27 0.5× 20 0.4× 12 615
Michael H. Woo United States 18 269 0.9× 182 1.6× 272 2.5× 25 0.4× 10 0.2× 20 755
E Fink Germany 12 114 0.4× 38 0.3× 131 1.2× 28 0.5× 14 0.3× 42 391
Julie Chen United States 7 232 0.8× 59 0.5× 15 0.1× 20 0.3× 47 0.9× 10 467

Countries citing papers authored by Ken Cheng

Since Specialization
Citations

This map shows the geographic impact of Ken Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Cheng more than expected).

Fields of papers citing papers by Ken Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Cheng. The network helps show where Ken Cheng may publish in the future.

Co-authorship network of co-authors of Ken Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Cheng. A scholar is included among the top collaborators of Ken Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Cheng. Ken Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Mervyn G., Roshan L. Shrestha, Raj Chari, et al.. (2025). Protein Phosphatase 1 Regulatory Subunit PNUTS Prevents CENP-A Mislocalization and Chromosomal Instability. Molecular and Cellular Biology. 45(5). 185–197.
2.
Huang, Tzu‐Ting, et al.. (2024). AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer. Cancer Research. 84(6). 887–904. 13 indexed citations
3.
Hammond, Colin M., Ivo A. Hendriks, Lu Chen, et al.. (2024). DNAJC9 prevents CENP-A mislocalization and chromosomal instability by maintaining the fidelity of histone supply chains. The EMBO Journal. 43(11). 2166–2197. 7 indexed citations
4.
Nair, Jayakumar R., Tzu‐Ting Huang, Ken Cheng, et al.. (2024). Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancer. iScience. 27(12). 111283–111283. 2 indexed citations
5.
Huang, Tzu‐Ting, Jayakumar R. Nair, Daniel An, et al.. (2023). BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer. Science Translational Medicine. 15(701). eadd7872–eadd7872. 17 indexed citations
6.
Luo, Shiyun, Yawen Zhao, Shanshan Zhu, et al.. (2022). Flavonifractor plautii Protects Against Elevated Arterial Stiffness. Circulation Research. 132(2). 167–181. 40 indexed citations
7.
8.
Murai, Yasuhisa, Ukhyun Jo, Junko Murai, et al.. (2021). SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243. Cancer Research. 81(11). 3067–3078. 33 indexed citations
9.
Jo, Ukhyun, Yasuhisa Murai, Sirisha Chakka, et al.. (2021). SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors. Proceedings of the National Academy of Sciences. 118(6). 51 indexed citations
10.
Martinez, Natalia J., John Braisted, Patricia Dranchak, et al.. (2021). Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery. ACS Pharmacology & Translational Science. 4(4). 1422–1436. 5 indexed citations
11.
Cai, Lisheng, Jeih‐San Liow, Cheryl L. Morse, et al.. (2020). Evaluation of 11C-NR2B-SMe and Its Enantiomers as PET Radioligands for Imaging the NR2B Subunit Within the NMDA Receptor Complex in Rats. Journal of Nuclear Medicine. 61(8). 1212–1220. 12 indexed citations
12.
Yasgar, Adam, Darrell L. Peterson, Alexey Zakharov, et al.. (2020). Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors. ACS Combinatorial Science. 22(8). 422–432. 14 indexed citations
13.
Coussens, Nathan P., Stephen C. Kales, Mark J. Henderson, et al.. (2018). High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2. Journal of Biological Chemistry. 293(35). 13750–13765. 55 indexed citations
14.
Baird, T., Ken Cheng, Yu‐Chi Chen, et al.. (2018). ICE1 promotes the link between splicing and nonsense-mediated mRNA decay. eLife. 7. 44 indexed citations
15.
Li, Jian, Jing Yuan, Ken Cheng, James Inglese, & Xin‐zhuan Su. (2013). Chemical genomics for studying parasite gene function and interaction. Trends in Parasitology. 29(12). 603–611. 5 indexed citations
16.
Mott, Bryan T., Ken Cheng, Rajarshi Guha, et al.. (2012). A furoxan–amodiaquine hybrid as a potential therapeutic for three parasitic diseases. MedChemComm. 3(12). 1505–1505. 20 indexed citations
17.
Yuan, Jing, Ken Cheng, Ronald L. Johnson, et al.. (2011). Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets. Science. 333(6043). 724–729. 114 indexed citations
18.
Snyder, John K., Scott C. Benson, Lily Lee, et al.. (2011). Truncated Aspidosperma Alkaloid-Like Scaffolds: Unique Structures for the Discovery of New, Bioactive Compounds. Heterocycles. 84(1). 135–135. 3 indexed citations
19.
Brown, Lauren E., Ken Cheng, Wanguo Wei, et al.. (2011). Discovery of new antimalarial chemotypes through chemical methodology and library development. Proceedings of the National Academy of Sciences. 108(17). 6775–6780. 37 indexed citations
20.
Ignjatović, Vera, Janine Furmedge, Fiona Newall, et al.. (2005). Age-related differences in heparin response. Thrombosis Research. 118(6). 741–745. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony J. Chubb Breakdown of academic impact, for papers by Caroline Aquino Moreira-Nunes Breakdown of academic impact, for papers by Andrew K. Powell Breakdown of academic impact, for papers by Miki Kato Breakdown of academic impact, for papers by Marco Brughera Breakdown of academic impact, for papers by B.W. Noland Breakdown of academic impact, for papers by Jason M. Gow Breakdown of academic impact, for papers by Michael H. Woo Breakdown of academic impact, for papers by E Fink Breakdown of academic impact, for papers by Julie Chen
Rankless by CCL
2026